Variants of the IFI16 gene affecting the levels of expression of mRNA are associated with susceptibility to Behet disease

Journal of Rheumatology

Volumn 42, Issue 4, 2015, Pages 695-701

  Ortiz Fernández, Lourdes ^a   García Lozano, José Raúl ^a   Montes Cano, Marco Antonio ^a   Conde Jaldón, Marta ^a   Ortego Centeno, Norberto ^b   García Hernández, Francisco José ^a   Espinosa, Gerard ^c   Graña Gil, Genaro ^d   Sánchez Bursón, Juan ^e   Blanco, Ricardo ^f   Barnosi Marín, Ana Celia ^g   Solans, Roser ^h   Fanlo, Patricia ⁱ   Rodríguez Carballeira, Mónica ^j   Camps, Teresa ^k   Castañeda, Santos ^l   Núñez Roldán, Antonio ^a   Martín, Javier ^m   González Escribano, María Francisca ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^c Thorax Institute   (Spain)

^d Servicio de Reumatología   (Spain)

^e HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^f HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^g Hospital de Torrecardenas   (Spain)

^h HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

ⁱ Instituto de Investigación Sanitaria de Navarra   (Spain)

^j Servicio de Medicina Interna   (Spain)

^k Hospital Universitario Carlos Haya   (Spain)

^l HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^m INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

more..

Author keywords

AIM2; Beh et disease; IFI16; INFLAMMASOME

Indexed keywords

DOUBLE STRANDED DNA; MESSENGER RNA; IFI16 PROTEIN, HUMAN; INFLAMMASOME; NUCLEAR PROTEIN; PHOSPHOPROTEIN;

ADULT; AIM2 GENE; ALLELE; ARTICLE; BEHCET DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DDX58 GENE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENE; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; IFI16 GENE; IFIH1 GENE; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SENSOR; SINGLE NUCLEOTIDE POLYMORPHISM; TLR3 GENE; TLR7 GENE; TLR8 GENE; TLR9 GENE; ZBP1 GENE; GENETICS; MIDDLE AGED; YOUNG ADULT;

ADULT; ALLELES; BEHCET SYNDROME; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INFLAMMASOMES; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PHOSPHOPROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER; YOUNG ADULT;

EID: 84940486806     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.140949     Document Type: Article

References (39)

1. Mendes D, Correia M, Barbedo M, Vaio T, Mota M, Goncalves O, et al. Behcet's disease-a contemporary review. J Autoimmun 2009;32:178-88.
2. Gonzalez-Gay MA, Garcia-Porrua C, Branas F, Lopez-Lazaro L, Olivieri I. Epidemiologic and clinical aspects of Behcet's disease in a defined area of Northwestern Spain, 1988-1997. J Rheumatol 2000;27:703-7.
3. McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLoS Med 2006;3:e297.
4. Lehner T. The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behçet's disease. Int Rev Immunol 1997;14:21-32.
5. de Menthon M, Lavalley MP, Maldini C, Guillevin L, Mahr A. HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum 2009;61:1287-96.
6. Yazici H, Fresko I, Yurdakul S. Behçet's syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 2007;3:148-55.
7. Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T, et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet's disease susceptibility loci. Nat Genet 2010;42:703-6.
8. Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease. Nat Genet 2010;42:698-702.
9. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006;124:783-801.
10. Kawasaki T, Kawai T, Akira S. Recognition of nucleic acids by pattern-recognition receptors and its relevance in autoimmunity. Immunol Rev 2011;243:61-73.
11. Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, Ban T, et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007;448:501-5.
12. Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, Sharma S, et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 2010;11:997-1004.
13. Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, Caffrey DR, et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009;458:514-8.
14. Veeranki S, Duan X, Panchanathan R, Liu H, Choubey D. IFI16 protein mediates the anti-inflammatory actions of the type-I interferons through suppression of activation of caspase-1 by inflammasomes. PloS One 2011;6:e27040.
15. Fernandes-Alnemri T, Yu J-W, Datta P, Wu J, Alnemri ES. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 2009;458:509-13.
16. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002;10:417-26.
17. Arend WP, Palmer G, Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 2008;223:20-38.
18. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990;335:1078-80.
19. Garcia-Lozano JR, Torres B, Fernandez O, Orozco G, Alvarez-Marquez A, Garcia A, et al. Caspase 7 influences susceptibility to rheumatoid arthritis. Rheumatology 2007; 46:1243-7.
20. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5.
21. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.
22. Epstein MP, Satten GA. Inference on haplotype effects in case-control studies using unphased genotype data. Am J Hum Genet 2003;73:1316-29.
23. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr 1974;19:716-23.
24. Düzgün N, Aya?lio?lu E, Tutkak H, Aydintu? OT. Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behçet's disease. Rheumatol Int 2005;25:1-5.
25. Musabak U, Pay S, Erdem H, Simsek I, Pekel A, Dinc A, et al. Serum interleukin-18 levels in patients with Behçet's disease. Is its expression associated with disease activity or clinical presentations? Rheumatol Int 2006;26:545-50.
26. Hamzaoui K, Kaabachi W, Fazaa B, Zakraoui L, Mili-Boussen I, Haj-Sassi F. Serum IL-33 levels and skin mRNA expression in Behçet's disease. Clin Exp Rheumatol 2013;31:6-14.
27. Gül A, Tugal-Tutkun I, Dinarello CA, Reznikov L, Esen BA, Mirza A, et al. Interleukin-1?-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study. Ann Rheum Dis 2012;71:563-6.
28. Liang L, Tan X, Zhou Q, Zhu Y, Tian Y, Yu H, et al. IL-1? triggered by peptidoglycan and lipopolysaccharide through TLR2/4 and ROS-NLRP3 inflammasome-dependent pathways is involved in ocular Behçet's disease. Invest Ophthalmol Vis Sci 2013; 54:402-14.
29. Dombrowski Y, Peric M, Koglin S, Kammerbauer C, Göss C, Anz D, et al. Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions. Sci Transl Med 2011;3:82ra38.
30. de Koning HD, Bergboer JG, van den Bogaard EH, van Vlijmen-Willems IM, Rodijk-Olthuis D, Simon A, et al. Strong induction of AIM2 expression in human epidermis in acute and chronic inflammatory skin conditions. Exp Dermatol 2012; 21:961-4.
31. Türe-Özdemir F, Tulunay A, Elbasi MO, Tatli I, Maurer A-M, Mumcu G, et al. Pro-inflammatory cytokine and caspase-1 responses to pattern recognition receptor activation of neutrophils and dendritic cells in Behcet's disease. Rheumatology 2013; 52:800-5.
32. Veeranki S, Choubey D. Interferon-inducible p200-family protein IFI16, an innate immune sensor for cytosolic and nuclear double-stranded DNA: regulation of subcellular localization. Mol Immunol 2012;49:567-71.
33. Guarda G, Braun M, Staehli F, Tardivel A, Mattmann C, Förster I, et al. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 2011;34:213-23.
34. Duan X, Ponomareva L, Veeranki S, Panchanathan R, Dickerson E, Choubey D. Differential roles for the interferon-inducible IFI16 and AIM2 innate immune sensors for cytosolic DNA in cellular senescence of human fibroblasts. Mol Cancer Res 2011;9:589-602.
35. Fei Y, Webb R, Cobb BL, Direskeneli H, Saruhan-Direskeneli G, Sawalha AH. Identification of novel genetic susceptibility loci for Behcet's disease using a genome-wide association study. Arthritis Res Ther 2009;11:R66.
36. Hou S, Yang Z, Du L, Jiang Z, Shu Q, Chen Y, et al. Identification of a susceptibility locus in STAT4 for Behçet's disease in Han Chinese in a genome-wide association study. Arthritis Rheum 2012;64:4104-13.
37. Lee YJ, Horie Y, Wallace GR, Choi YS, Park JA, Choi JY, et al. Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behcet's disease. Ann Rheum Dis 2013;72:1510-6.
38. Kirino Y, Bertsias G, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E, et al. Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B51 and ERAP1. Nat Genet 2013;45:202-7.
39. Ortiz-Fernandez L, Conde-Jaldon M, Garcia-Lozano JR, Montes-Cano MA, Ortego-Centeno N, Castillo-Palma MJ, et al. GIMAP and Behcet disease: no association in the European population. Ann Rheum Dis 2014;73:1433-4.